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ABSTRACT
Purpose: This study investigated the validity of the Charlson comorbidity index (CCI) as a 
predictor of periodontal disease (PD) over a 12-year period.
Methods: Nationwide representative samples of 149,785 adults aged ≥60 years with PD 
(International Classification of Disease, 10th revision [ICD-10], K052–K056) were derived 
from the National Health Insurance Service-Elderly Cohort during 2002–2013. The degree 
of comorbidity was measured using the CCI (grade 0–6), including 17 diseases weighted on 
the basis of their association with mortality, and data were analyzed using multivariate Cox 
proportional-hazards regression in order to investigate the associations of comorbid diseases 
(CDs) with PD.
Results: The multivariate Cox regression analysis with adjustment for sociodemographic 
factors (sex, age, household income, insurance status, residence area, and health status) 
and CDs (acute myocardial infarction, congestive heart failure, peripheral vascular disease, 
cerebral vascular accident, dementia, pulmonary disease, connective tissue disorders, peptic 
ulcer, liver disease, diabetes, diabetes complications, paraplegia, renal disease, cancer, 
metastatic cancer, severe liver disease, and human immunodeficiency virus [HIV]) showed 
that the CCI in elderly comorbid participants was significantly and positively correlated with 
the presence of PD (grade 1: hazard ratio [HR], 1.11; P<0.001; grade ≥2: HR, 1.12, P<0.001).
Conclusions: We demonstrated that a higher CCI was a significant predictor of greater risk 
for PD in the South Korean elderly population.
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INTRODUCTION
Chronic periodontal disease (PD) is a bacteria-induced chronic inflammatory disease. Although 
several aspects of this disease remain controversial, it is known to share proinflammatory 
cytokines and mediators with various lifestyle-related comorbid diseases (CDs), such as 
cardiovascular disease, pulmonary disease, diabetes mellitus, rheumatoid arthritis, vasculogenic 
erectile dysfunction, osteoporosis, and cancer [1-5]. These CDs may act as risk factors for PD, and 
PD can simultaneously be a risk indicator or risk factor for these comorbid conditions [6].
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Many recent studies have found associations between PD and mortality from CDs. LaMonte 
et al. [7] reported that the presence of severe PD in elderly women increased their risk of 
total mortality by 12% (hazard ratio [HR], 1.12; 95% confidence interval [CI], 1.05–1.21; 
P=0.002). Sharma et al. [8] further reported that the 10-year all-cause mortality rates of 
patients with chronic kidney disease were 32% and 41% without and with PD, respectively. 
Moreover, Saremi et al. [9] reported a 3.2-fold increase (95% CI, 1.1–9.3) in cardiorenal 
mortality (ischemic heart disease and diabetic nephropathy combined) when patients with 
PD were followed up for an average of 11 years, indicating that PD may be a major predictor 
of mortality due to ischemic heart disease and diabetic nephropathy. These findings indicate 
that PD is very common in elderly patients with CDs and may also be associated with health 
decline and mortality.
Evaluating systemic diseases in a patient before initiating treatment can be useful for 
predicting treatment results, such as the re-admission, re-operation, complication, and 
mortality rates; the validity of these factors has been evaluated in various clinical areas, 
and new evaluation methods are continuously being developed. Several methods, such 
as the Charlson comorbidity index (CCI), the Cumulative Illness Rating Scale, the Index 
of Coexistent Disease, and the Kaplan-Feinstein Scale, have been developed for the 
comprehensive and systematic assessment of CDs [10]. The CCI is the most widely used tool 
for estimating the prognosis of patients with CDs [11]. The use of this index with weights 
that vary (from 1 to 6) according to the severity of different diseases was shown to be effective 
in predicting the 1-year mortality rate based on the following 19 conditions: myocardial 
infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, 
dementia, chronic pulmonary disease, connective tissue disease, peptic ulcer disease, mild 
liver disease, diabetes without end-organ damage, hemiplegia, moderate or severe renal 
disease, diabetes with end-organ damage, tumor without metastases, leukemia, lymphoma, 
moderate or severe liver disease, metastatic solid tumor, and acquired immunodeficiency 
syndrome (AIDS) [11].
Although results from many studies have consistently supported using the CCI as a 
significant and independent prognostic indicator in various cancers and inflammatory 
diseases, the prognostic significance of this index has not been validated in PD patients, 
including elderly PD patients [12,13]. Therefore, the aim of the present study was to 
determine the validity of the CCI as a predictor of PD in elderly participants using the 
database of the nationwide population-based National Health Insurance Service-Elderly 
Cohort (NHIS-EC), which was newly released in 2016.
MATERIALS AND METHODS
Study design and data collection
This study selected 5.1 million elderly people (older than 60 years at the end of December 
2002) during 2002 and 2003 as the entire population, from which 10% (n=558,147) were 
sampled by simple stratification by the National Health Insurance Service (NHIS) Big Data 
Steering Department. This database covered the following parameters: sociodemographic 
and socioeconomic information, insurance status, health check-up examinations, and 
records of patients' medical and dental history. These parameters were stratified to cover 12 
years (2002–2013) and anonymized to protect individuals' privacy within the cohort study.
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This study conformed to the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) guidelines for reporting observational cohort studies (www.
strobe-statement.org) and was approved by the Institutional Review Board of Daejeon Dental 
Hospital, Wonkwang University (approval No. W1704/001-001).
Definition of sociodemographic factors
The following potential confounding sociodemographic factors of PD were collected from 
the NHIS-EC database and assessed: sex, age (6 groups: those aged 60–84 years in 5-year 
intervals, and those aged ≥85 years), household income (5 groups: those with area-based 
[10 groups] and job-based [10 groups] health insurance were divided into 5 quintiles, with 
the Medical Aid Program [MAP] included in the first quintile), insurance status (3 groups: 
classified into the MAP group and NHIS [employees and self-employed] groups), residence 
area (3 groups: classified into metropolitan [≥10 million], urban [≥1 million], and others), 
and health status (3 groups: those classified as healthy, and with major and minor disabilities 
according to the Handicapped Welfare Law). All participants with responses regarding 
sociodemographic factors with either missing or unknown parameters were excluded from 
the current analysis.
Assessment of the CCI and PD
Elderly patients diagnosed with PD and CDs corresponding to the CCI prior to 2002 were 
excluded from the analysis, and the baseline was then established. Among the patients who had 
been diagnosed with CDs, we assessed the CCI during the follow-up period from 2002 to 2003. 
The CCI with International Classification of Disease, 10th revision (ICD-10) codes has been 
verified by Deyo et al. [14] and Sundararajan et al. [15], and we defined CDs using the ICD-10 
codes provided by Sundararajan et al. [15]. The CCI assigns a weight of 1–6 points to each CD as 
follows, with the sum of individual scores serving as a measure of the overall comorbidity of a 
participant. If the weight was 0, the CDs listed below were not diagnosed (Table 1):
• 1 point was assigned for a history of acute myocardial infarction (including coronary artery 
bypass graft, percutaneous transluminal coronary angioplasty, and angina pectoris; codes 
I21, I22, and I252, respectively), congestive heart failure (I50), peripheral vascular disease 
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Table 1. ICD-10 codes and weights for the CCI scoring system
Condition Weighting Codes (ICD-10)
Acute myocardial infarctiona) 1 I21, I22, I252
Congestive heart failure 1 I50
Peripheral vascular disease 1 I71, I739, I790, R02, Z958, Z959
Cerebral vascular accident 1 I60–69, G450–452, G454, G458, G459, G46
Dementia 1 F00–F02, F051
Pulmonary disease 1 J40–J47, J61–J67
Connective tissue disorders 1 M32–M35, M058–M060, M063, M069
Peptic ulcer 1 K25–K28
Liver disease 1 K702, K703, K717, K73, K740, K742–K746
Diabetes 1 E101, E105, E109, E111, E115, E119, E131, E135, E139, E141, E145, E149
Diabetes complications 2 E102–104, E112–114, E132–134, E142–144
Paraplegia 2 G041, G81–G822
Renal disease 2 N01, N03, N052–N056, N072, N18, N19, N25
Cancer 2 C0–C96
Metastatic cancer 3 C77–C80
Severe liver disease 3 K721, K729, K766, K767
HIV 6 B20–B24
ICD-10: International Classification of Disease, 10th revision, CCI: Charlson comorbidity index, HIV: human immunodeficiency virus.
a)Including coronary artery bypass graft, percutaneous transluminal coronary angioplasty, and angina pectoris.
(I71, I739, I790, R02, Z958, and Z959), cerebral vascular accident (I60–I69, G450–G452, 
G454, G458, G459, and G46), dementia (F00–F02 and F051), pulmonary disease (J40–J47 
and J61–J67), connective tissue disorders (M32–M35, M058–M060, M063, and M069), peptic 
ulcer (K25–K28), liver disease (K702, K703, K717, K73, K740, and K742–K746), and diabetes 
without end-organ damage (E101, E105, E109, E111, E115, E119, E131, E135, E139, E141, E145, 
and E149).
• 2 points were assigned for diabetes complications (E102–104, E112–114, E132–134, and 
E142–144), paraplegia (G041 and G81–G822), renal disease (N01, N03, N052–N056, N072, 
N18, N19, and N25), and cancer (C0–C96).
• 3 points were assigned for metastatic cancer (C77–C80) and severe liver disease (K721, 
K729, K766, and K767).
• 6 points were assigned for human immunodeficiency virus [HIV] (B20–B24).
Participants who were diagnosed with PD prior to 2003 were excluded, and we included 
participants who were newly diagnosed with PD (acute periodontitis [ICD-10, K052], 
chronic periodontitis [K053], periodontosis [K054], other periodontal disease [K055], and 
unspecified periodontal disease [K056]) and who received periodontal treatment (including 
NHIS prescription codes: U1010, subgingival curettage; U1020, excisional new attachment 
procedure; U1051–1052, simple/complex periodontal flap operation; U1071–1072, bone graft 
for alveolar bone defects; or U1081–1083, guided tissue regeneration) based on the guidelines 
of the Centers for Disease Control and American Academy of Periodontology using dental 
history questionnaires, clinical signs, and an oral examination and radiographic evaluation 
by a registered general dentist or periodontist who was qualified to perform a dental check-up 
[16,17]. To increase the validity of the PD diagnoses obtained in this study, we only selected 
PD participants who had been diagnosed and treated at least twice from 2004 to 2013.
Statistical analysis
We calculated HRs with 95% CIs using multivariate Cox proportional-hazards regression 
analysis, adjusting for sociodemographic factors (sex, age, household income, insurance 
status, residence area, and health status) and CDs (acute myocardial infarction, congestive 
heart failure, peripheral vascular disease, cerebral vascular accident, dementia, pulmonary 
disease, connective tissue disorders, peptic ulcer, liver disease, diabetes, diabetes 
complications, paraplegia, renal disease, cancer, metastatic cancer, severe liver disease, and 
HIV). The cumulative incidence of PD in participants with CDs was estimated using a Kaplan-
Meier curve, with differences assessed using the log-rank test. All statistical tests were 
2-sided, and a P value of <0.05 was considered to indicate statistical significance. Analyses 
were performed using SAS (version 9.2, SAS Institute, Cary, NC, USA) by the Department of 
Health Insurance Research, Ilsan Hospital, NHIS.
RESULTS
Results for the CCI and the incidence of PD in participants with CDs
Table 2 presents the data for the incidence of CDs in study subjects with PD. The incidence of 
CDs in participants with PD was highest for pulmonary disease (n=123,556, 82.5%), followed 
by peptic ulcer (n=123,191, 82.2%), liver disease (n=105,157, 70.2%), diabetes (n=91,047, 
60.8%), peripheral vascular disease (n=80,058, 53.4%), cerebral vascular accident (n=72,245, 
48.2%), connective tissue disorders (n=45,401, 30.3%), cancer (n=44,294, 29.6%), congestive 
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heart failure (n=38,669, 25.8%), dementia (n=30,678, 20.5%), acute myocardial infarction 
(n=15,929, 10.6%), renal disease (n=9,723, 6.5%), severe liver disease (n=9,403, 6.3%), 
metastatic cancer (n=5,945, 4.0%), diabetes complications (n=5,185, 3.5%), paraplegia 
(n=1,452, 1.0%), and HIV (n=130, 0.1%).
Associations of the CCI with incident PD in elderly participants
Figure 1 presents the adjusted Kaplan-Meier curve for elderly comorbid participants with 
PD and a known CCI. Higher CCIs were associated with a higher incidence of PD in elderly 
comorbid participants (P<0.001). As indicated in Figure 2, the multivariate Cox proportional-
hazards regression analysis with adjustment for sociodemographic factors, CCI, and CDs 
showed that the incidence of PD in elderly comorbid participants had a significant positive 
relationship with household income, insurance status, the CCI, peripheral vascular disease, 
cerebral vascular accident, pulmonary disease, connective tissue disorders, peptic ulcer, liver 
disease, diabetes, and cancer.
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Table 2. Incidence of comorbid diseases corresponding to the CCI together with periodontal disease in the study subjects
Condition Weighting Males (n=65,817) No. (%) Females (n=83,968) No. (%) Pa)
Acute myocardial infarction 1 7,768 (11.8) 8,161 (9.7) <0.001
Congestive heart failure 1 14,793 (22.5) 23,876 (28.4) <0.001
Peripheral vascular disease 1 31,753 (48.2) 48,305 (57.5) <0.001
Cerebral vascular accident 1 29,884 (45.4) 42,361 (50.4) <0.001
Dementia 1 10,930 (16.6) 19,748 (23.5) <0.001
Pulmonary disease 1 53,354 (81.1) 70,202 (83.6) <0.001
Connective tissue disorders 1 14,155 (21.5) 31,246 (37.2) <0.001
Peptic ulcer 1 52,309 (79.5) 70,882 (84.4) <0.001
Liver disease 1 45,961 (69.8) 59,196 (70.5) <0.001
Diabetes 1 38,838 (59.0) 52,209 (62.2) <0.001
Diabetes complications 2 2,172 (3.3) 3,013 (3.6) <0.001
Paraplegia 2 667 (1.0) 785 (0.9) <0.001
Renal disease 2 5,292 (8.0) 4,431 (5.3) <0.001
Cancer 2 25,718 (39.1) 18,576 (22.1) <0.001
Metastatic cancer 3 3,081 (4.7) 2,864 (3.4) <0.001
Severe liver disease 3 5,764 (8.8) 3,639 (4.3) <0.001
HIV 6 67 (0.1) 63 (0.1) <0.001
CCI: Charlson comorbidity index, HIV: human immunodeficiency virus.
a)All P values from the χ2 test are significantly statistics (P<0.05).
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Figure 1. The cumulative incidence of PD in patients with CDs was estimated using the Kaplan-Meier method 
and compared using the log-rank test. A higher CCI was associated with a higher incidence of PD in elderly 
participants with comorbidities (P<0.001). 
PD: periodontal disease, CD: comorbid disease, CCI: Charlson comorbidity index.
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Condition HR (95% CI) HR (95% CI) P
Sex (ref: male)  
Female 0.92 (0.91–0.93) <0.001
Age group (ref: 60–64 years)
65–69 0.68 (0.68–0.70) <0.001
70–74 0.43 (0.43–0.44) <0.001
75–79 0.26 (0.24–0.25) <0.001
80–84 0.12 (0.11–0.12) <0.001
≥85 0.04 (0.04–0.05) <0.001
Household income (ref: first)
Second quintile 0.99 (0.97–1.01) 0.606
Third quintile 1.08 (1.05–1.10) <0.001
Fourth quintile 1.21 (1.18–1.23) <0.001
Fifth quintile 1.56 (1.53–1.59) <0.001
Insurance (ref: MAP)
NHIS (employees) 1.58 (1.53–1.64) <0.001
NHIS (self-employed) 1.38 (1.33–1.42) <0.001
Residence (ref: metropolitan)
Urban (>one million) 0.86 (0.84–0.87) <0.001
Others 0.63 (0.61–0.64) <0.001
Health status (ref: healthy)
Disability 0.70 (0.63–0.78) <0.001
CCI (ref: 0)
1 1.11 (1.09–1.12) <0.001
2 1.12 (1.10–1.14) <0.001
Comorbidity (ref: normal)
Acute myocardial infarction 0.85 (0.83–0.87) <0.001
Congestive heart failure 0.87 (0.83–0.87) <0.001
Peripheral vascular disease 1.25 (1.23–1.26) <0.001
Cerebral vascular accident 1.01 (1.00–1.03) 0.006
Dementia 0.88 (0.86–0.89) <0.001
Pulmonary disease 1.34 (1.32–1.36) <0.001
Connective tissue disorders 1.19 (1.17–1.20) <0.001
Peptic ulcer 1.37 (1.34–1.39) <0.001
Liver disease 1.29 (1.27–1.31) <0.001
Diabetes 1.18 (1.17–1.20) <0.001
Diabetes complications 0.86 (0.83–0.89) <0.001
Paraplegia 0.83 (0.78–0.88) <0.001
Renal disease 0.89 (0.87–0.91) <0.001
Cancer 1.04 (1.02–1.06) <0.001
Metastatic cancer 0.82 (0.79–0.84) <0.001
Severe liver disease 0.66 (0.64–0.68) <0.001
HIV 1.00 (0.81–1.25) 0.932
1.2 1.4 1.60.2 0.4 0.80.6 1.0
Figure 2. Associations of comorbidities with PD in elderly participants in the multivariate regression analysis. The multivariate Cox proportional-hazards 
regression analysis adjusted for sex, age, household income, insurance status, residence area, health status, acute myocardial infarction, congestive heart 
failure, peripheral vascular disease, cerebral vascular accident, dementia, pulmonary disease, connective tissue disorders, peptic ulcer, liver disease, diabetes, 
diabetes complications, paraplegia, renal disease, cancer, metastatic cancer, severe liver disease, and HIV. Data are HRs with 95% CIs. 
PD: periodontal disease, HIV: human immunodeficiency virus, HR: hazard ratio, CI: confidence interval, MAP: Medical Aid Program, NHIS: National Health 
Insurance Service, CCI: Charlson comorbidity index.
DISCUSSION
Targeting elderly individuals aged 60 years or older in South Korea, the present study is the 
first to quantify the usefulness of the CCI as a tool for evaluating CDs that are predictive 
factors for PD. CDs refer to chronic diseases that coexist or are present at the time of 
diagnosis of the disease under consideration. More than 50% of patients with cancer are 
generally reportedly to have CDs, including hypertension, diabetes mellitus, pulmonary 
disease, and cardiovascular disease [18]. The present study similarly found that 51.2% of 
participants with PD had CDs that were included in the CCI.
Female participants showed a slightly lower risk of PD than male participants (HR, 0.92; 95% 
CI, 0.91–0.93; P<0.001), which is consistent with the finding of a recent systematic review 
that male patients generally had a similar or a higher prevalence of PD than female patients 
[19]. Most studies have found that the morbidity rate of PD increased significantly with age 
[20,21]. However, the present study found that the HR for PD decreased with age, especially 
for the age range of 60–64 years; this might be attributable to fewer subjects visiting dentists 
and being diagnosed with PD compared to those visiting a hospital for CDs. In other words, 
this might have occurred because the proportion of participants who were diagnosed with 
PD by dentists decreased when they had severe concomitant physical or mental diseases 
that limited their access to dental services [22,23]. This is supported by the consistent 
observation of low HRs for PD among those with low income levels who lived in areas with a 
lower accessibility of dentists and had physical disorders.
The HR values for PD associated with CCIs of 1 and ≥2 were 1.11 (95% CI, 1.09–1.12; 
P<0.001) and 1.12 (95% CI, 1.10–1.14; P<0.001), respectively, meaning that PD appeared to 
be associated with an increase in the severity of — and mortality associated with — CDs. 
In particular, the results of the 12-year Kaplan-Meier analysis showed that the risk of PD 
increased significantly with the CCI. Analyzing the distribution of the CDs revealed the 
following distribution of increased risks for PD: 37% for peptic ulcer, 34% for pulmonary 
disease, 29% for liver disease, 25% for peripheral vascular disease, 19% for connective-tissue 
disorder, 18% for diabetes, 4% for cancer, and 1% for cerebral vascular accidents. Acute 
myocardial infarction, congestive heart failure, and dementia were CDs associated with 
lower risks of PD. Since acute myocardial infarction and congestive heart failure are diseases 
with high mortality rates, it can be postulated that individuals with those diseases would be 
unlikely to visit dentists to be diagnosed with PD, resulting in them showing lower risks in 
the present study [24]. Despite reports that tooth loss and PD worsen cognitive function, and 
the presence of shared inflammatory mediators with Alzheimer disease, a recent systematic 
review argued that the foundations for a direct correlation between PD and Alzheimer disease 
were insufficient and controversial [25].
Among the CDs included in the CCI, the HRs for peptic ulcer disease indicated that chronic 
gastritis, peptic ulcer, gastric carcinoma, and gastric mucosa-associated lymphoid tissue 
lymphoma showed the strongest associations with PD. Helicobacter pylori has been suspected 
to be one of the main causes of peptic ulcer disease [26]. Despite being easily treatable,  
H. pylori has a high re-infection rate, and the lifetime risk of peptic ulcer disease (once 
infection occurs) is as high as 10% to 20% [27]. The suspected major pathways of re-
infection are dental plaque, poor oral hygiene, and PD [28]. Treating peptic ulcer disease 
in combination with periodontal treatment was approximately 30% more successful at 
eradicating gastric H. pylori than conventional triple therapy (antibiotics, antimicrobials, and 
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proton-pump inhibitors) without periodontal treatment [29]. Therefore, elderly participants, 
who tend to have poor oral hygiene and limited access to periodontal treatment, may be more 
likely to develop chronic PD; it is postulated that these factors may further increase the risk of 
the recurrence of peptic ulcer disease. No studies have investigated the effects of peptic ulcer 
disease on PD, meaning that the underlying mechanisms remain to be investigated.
The CDs with the second highest risk — pulmonary diseases such as pneumonia and 
chronic obstructive pulmonary disease — have also been found to be risk factors for PD in 
many studies, including a systematic review [30,31]. As with peptic ulcer disease, potential 
respiratory pathogens have been found in dental plaque, and they have been considered 
major sources of respiratory infection [32]. Sumi et al. [32] reported that the respiratory 
pathogens Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Enterobacter 
cloacae accounted for most of the pathogens in the dental plaque of elderly individuals. In 
particular, pneumonia is a life-threatening infection that is a significant risk factor for 
mortality in the elderly [33]. We found that pulmonary diseases, which are major contributors 
to morbidity and mortality, increased the risk of PD in the elderly by 34%. Although the study 
of pulmonary disease as a risk factor for PD is very limited, these observations suggest that 
pulmonary disease has substantial implications not only for oral health, but also for the 
entire public health sector.
Many researchers have confirmed that CDs are important predictive factors for health 
[34,35]. Chronic PD is rapidly becoming a global epidemic disease with an increasing 
prevalence worldwide, particularly in elderly populations. According to a report of the Health 
Insurance Review and Assessment Service in 2016, PD has been the most expensive health 
problem in South Korea (amounting to about US$ 1 billion) and the second-most-frequent 
disease (about 26.3% [13 million] of the Korean population) among outpatients since 2011. 
In addition, consistent with the general trend in developed countries, the elderly population 
is rapidly growing in South Korea, which is predicted to be a super-aged society — defined 
as more than 20% of the population being aged 65 years or older — by 2020. In the present 
study, the risk factors for PD increased the incidence of CDs and healthcare costs to different 
extents, depending on the severity of the CDs, which suggests that more in-depth evaluation 
and management are required before establishing appropriate policies for dental health 
care. Thus, the risk of PD may be especially high for CDs associated with high CCI values 
(which are the most severe types of CDs), and so elderly participants with CDs should be 
actively informed of their elevated risk for PD and advised to seek appropriate medical and 
periodontal care.
This study was subject to several limitations. First, the analysis was unable to reflect various 
clinical outcomes due to the inherent limitations of the retrospective NHIS-EC data. It poorly 
reflected the detailed characteristics of the risk factors, particularly the severity and duration 
of PD and CDs. Second, another major weakness of this study is that smoking and remaining 
teeth were not assessed, although many previous studies have found these to be important 
confounding factors for PD [36]. Third, selection bias can occur due to the cohort design, 
and in particular the inclusion of only patients who visited dental and medical clinics and 
who were diagnosed with PD and CDs. Fourth, owing to the study design (which established 
the baseline as the period between 2002 and 2003), participants' sociodemographic and 
socioeconomic position could have changed during the follow-up period, which extended 
through 2013. We accept that this study failed to consider this point, making it a limitation of 
this study. Finally, the CCI used in this study was developed in 1986; it is currently recognized 
https://doi.org/10.5051/jpis.2018.48.2.92
Periodontitis and Charlson comorbidity index
https://jpis.org 99
for its usefulness and validity, but new weights should continuously be developed as medical 
technology evolves. Quantifying the usefulness of the CCI as a predictor of PD will require the 
development of novel evaluation tools for CDs based on the most recent medical knowledge.
This 12-year longitudinal cohort study provides evidence that a high CCI was significantly 
associated with a higher risk of PD in the South Korean elderly population. Although 
the significant associations reported here must be confirmed by further studies, these 
observations have potentially important implications not only for oral health, but also for the 
entire public health sector.
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